Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McGill University

$27,000.00

A Novel Approach to Enhance Craniofacial Bone Regeneration via STING Inhibition

FY 2025-26

Summary
Large cranial bone defects can occur after tumor removal, severe skull injuries, or complications from reconstructive surgery, which defects are hard to repair. The current gold-standard treatment for large cranial bone defects involves the use of autologous bone grafts. However, this approach is associated with significant limitations, including limited donor bone, complications at the donor site, and the risk of graft failure or shrinkage. As a result, many patients with large cranial defects require additional reconstructive surgeries and autologous bone grafting. Monetite, which is a biocompatible biomaterial that promotes new bone growth, has shown promise in bone regeneration; however, these biomaterials often yield inconsistent clinical outcomes due to immune activation at the transplant site, causing biomaterial resorption and reduced bone deposition. My research aims to develop an effective therapy to improve healing in large cranial bone defects. This approach combines a bone-forming biomaterial with immune modulated treatment to accelerate bone regeneration by regulating the STING pathway, which immune pathway suppresses bone growth when activated. In this project, I will test if the use of a biomaterial combined with STING inhibitor enhances bone repair in a cranial bone defect animal model. I expect that this therapy will increase the rate and quantity of new bone formation and provide new insights into how immune pathways affect bone healing. If successful, this bone-healing strategy could reduce the requirement for bone grafts, leading to lower treatment costs, and shorter recovery times. Ultimately, this research could lead to more effective and less invasive treatments for patients with large cranial bone defects, improving recovery and quality of life.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573025
Name
Xie Dongyue
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Novel Approach to Enhance Craniofacial Bone Regeneration via STING Inhibition
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Bioceramics; Bioinorganic; Biomaterial; Bone Regeneration; Immunomodulation; Innate Immune System; Sting Pathway; Surgical Innovation; Tissue Engineering
Abstract
Large cranial bone defects can occur after tumor removal, severe skull injuries, or complications from reconstructive surgery, which defects are hard to repair. The current gold-standard treatment for large cranial bone defects involves the use of autologous bone grafts. However, this approach is associated with significant limitations, including limited donor bone, complications at the donor site, and the risk of graft failure or shrinkage. As a result, many patients with large cranial defects require additional reconstructive surgeries and autologous bone grafting. Monetite, which is a biocompatible biomaterial that promotes new bone growth, has shown promise in bone regeneration; however, these biomaterials often yield inconsistent clinical outcomes due to immune activation at the transplant site, causing biomaterial resorption and reduced bone deposition. My research aims to develop an effective therapy to improve healing in large cranial bone defects. This approach combines a bone-forming biomaterial with immune modulated treatment to accelerate bone regeneration by regulating the STING pathway, which immune pathway suppresses bone growth when activated. In this project, I will test if the use of a biomaterial combined with STING inhibitor enhances bone repair in a cranial bone defect animal model. I expect that this therapy will increase the rate and quantity of new bone formation and provide new insights into how immune pathways affect bone healing. If successful, this bone-healing strategy could reduce the requirement for bone grafts, leading to lower treatment costs, and shorter recovery times. Ultimately, this research could lead to more effective and less invasive treatments for patients with large cranial bone defects, improving recovery and quality of life.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Xie, Dongyue
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~